← Back to Clinical Trials
Recruiting NCT05214651

NCT05214651 A Clinical Research on Repair of Massive-large Rotator Cuff Tears

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05214651
Status Recruiting
Phase
Sponsor Peking University Third Hospital
Condition Rotator Cuff Tears
Study Type INTERVENTIONAL
Enrollment 52 participants
Start Date 2022-06-08
Primary Completion 2026-05

Trial Parameters

Condition Rotator Cuff Tears
Sponsor Peking University Third Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 52
Sex ALL
Min Age 17 Years
Max Age 75 Years
Start Date 2022-06-08
Completion 2026-05
Interventions
novel double rowsuture bridge double row

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study is designed as a randomized controlled trial, a total of 52 participants with large - massive rotator cuff tears will be prospectively enrolled and randomly divided into 2 groups according to the applied repairing technique: novel double row technique group and suture bridge double row technique group. The functional outcome was measured at the preoperatively, 3, 6, 12 and 24 months postoperatively, using the visual analog scale (VAS) for pain, active and passive ROM, Constant score, American Shoulder and Elbow Surgeons (ASES) score, and University of California Los Angeles shoulder score (UCLA). The anatomic outcome was evaluated using magnetic resonance imaging at 3, 6, 12 and 24 months postoperatively. The clinical results were compared between the novel double row technique group and suture bridge double row technique group.

Eligibility Criteria

Inclusion Criteria: * preoperative magnetic resonance imaging (MRI) diagnosis of a large - massive sized rotator cuff tear (\>3cm), which was confirmed during operation * chronic tear * older than 17 years and younger than 75 years * without surgical contraindications and willing to participate Exclusion Criteria: * poor quality rotator cuff and irreparable tear * severe glenohumeral arthritis * previous shoulder surgery * accompanied by dislocation or fracture of shoulder * refusal to participate

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology